Double vision (diplopia) is a serious and intolerable condition that can be caused by strabismus, ophthalmoplegia, gaze palsy, and decompensated binocular skills in patients with brain injury, stroke and other neurologically compromising conditions. Prisms, lenses and / or vision therapy can oftentimes help the patient achieve fusion (alignment of the eyes) and alleviate the diplopia. If and when these means are not employed, the patient may adapt by suppressing the vision of one eye to eliminate the diplopia. If lenses, prisms, and / or therapy are not successful and the patient does not suppress, intractable diplopia ensues.
In this population of patients, patching has frequently been used to eliminate the diplopia. Although patching is effective in eliminating diplopia it causes the patient to become monocular. Monocular as opposed to binocular vision will affect the individual primarily in two ways; absence of stereopsis and reduction of the peripheral field of vision. These limitations will directly cause problems in eye hand coordination, depth judgments, orientation, balance, mobility, and activities of daily living such as playing sports, driving, climbing stairs, crossing the street, threading a needle etc.
A new method of treating diplopia that does not have these limitations has been successfully evaluated. It is called the “spot patch” (invented and named by this author) and is a method to eliminate intractable diplopia without compromising peripheral vision. It is a small, usually round or oval, patch made of dermacil tape, 3-M blurring film (or another such translucent tape). It is placed on the inside of the lenses of glasses and directly in the line of sight contributing to the diplopia. The diameter is generally about one centimeter, but will vary on the individual angular subtense required for the particular strabismus, or gaze palsy.